ArticleFrontiers in pharmacology2022

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects.

Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.